Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
Xuanwei Li; Wenlai Li; Yue Li; Chuanjiang Dong; Ping Zhu;
Nefrologia (English Version). 2023;43:731-41
Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020
Elisabet Ars; Carmen Bernis; Gloria Fraga; Mónica Furlano; Víctor Martínez; Judith Martins; Alberto Ortiz; Maria Vanessa Pérez-Gómez; José Carlos Rodríguez-Pérez; Laia Sans; Roser Torra;
Nefrologia (English Version). 2022;42:367-89
Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis
Ahmed W. Hageen; Reem Sayad; Alyaa Khaled Abdelmonem; Katia Latifa; Lina Musallam; Moustafa Abouelkheir; Sherif Mira; Ahmed Awad; Ahmed Afsa; Waleed Nassar; Gehad El Ashal; Mohamed Elmasry; Eshak I. Bahbah;
Nefrologia (English Version). 2025;45: